MAP3K10 and atherosclerosis: It has also been reported that miR-155 negatively regulates inflammatory cytokine production and slows the progression of atherosclerosis because it controls the inflammatory response by repressing the mitogen-activated protein kinase 10 (MAP3K10) pathway (36).